Role of AIM2 inflammasome in inflammatory diseases, cancer and infection

BR Sharma, R Karki… - European journal of …, 2019 - Wiley Online Library
AIM2 is a cytosolic innate immune receptor which recognizes double‐stranded DNA
(dsDNA) released during cellular perturbation and pathogenic assault. AIM2 recognition of …

Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis

PM Ridker - Circulation research, 2019 - Am Heart Assoc
The recognition that atherosclerosis is a complex chronic inflammatory disorder mediated
through both adaptive and innate immunity has led to the hypothesis that anticytokine …

Role of inflammatory cell subtypes in heart failure

D Strassheim, EC Dempsey… - Journal of …, 2019 - Wiley Online Library
Inflammation is a well‐known feature of heart failure. Studies have shown that while some
inflammation is required for repair during injury and is protective, prolonged inflammation …

[HTML][HTML] Potential role of polycyclic aromatic hydrocarbons as mediators of cardiovascular effects from combustion particles

JA Holme, BC Brinchmann, M Refsnes, M Låg… - Environmental …, 2019 - Springer
Air pollution is the most important environmental risk factor for disease and premature death,
and exposure to combustion particles from vehicles is a major contributor. Human …

[HTML][HTML] Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

LM Tsujikawa, L Fu, S Das, C Halliday, BD Rakai… - Clinical …, 2019 - Springer
Abstract Background Apabetalone (RVX-208) is a bromodomain and extraterminal protein
inhibitor (BETi) that in phase II trials reduced the relative risk (RR) of major adverse cardiac …

[HTML][HTML] Macrophage migration inhibitory factor (MIF)-based therapeutic concepts in atherosclerosis and inflammation

D Sinitski, C Kontos, C Krammer… - Thrombosis and …, 2019 - thieme-connect.com
Chemokines orchestrate leukocyte recruitment in atherosclerosis and their blockade is a
promising anti-atherosclerotic strategy, but few chemokine-based approaches have …

Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF‐κB/STAT3 Activation in Ox‐LDL‐Treated HUVECs

M Zhang, Y Xue, H Chen, L Meng… - Oxidative medicine …, 2019 - Wiley Online Library
Aim. Resveratrol is a natural plant polyphenol. The present study investigated the effects of
resveratrol on the Toll‐like receptor 4‐(TLR4‐) mediated expression and secretion of matrix …

Age-related diseases as vicious cycles

AV Belikov - Ageing research reviews, 2019 - Elsevier
The mortality rates of age-related diseases (ARDs) increase exponentially with age.
Processes described by the exponential growth function typically involve a branching chain …

Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis

B Aryal, Y Suárez - Vascular pharmacology, 2019 - Elsevier
The endothelial lining can be viewed as the first line of defense against risk factors of
vascular disease. Endothelial dysfunction is regarded as an initial event for atherogenesis …

Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease

Y Zhou, PJ Little, HT Ta, S Xu, D Kamato - Pharmacology & Therapeutics, 2019 - Elsevier
Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six
widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological …